Metabolism and Nutrition Research Group, Korea Food Research Institute, Seongnam, Korea; Division of Food Biotechnology, University of Science and Technology, Daejeon, Korea.
EMBO Mol Med. 2013 Oct;5(10):1602-12. doi: 10.1002/emmm.201302647. Epub 2013 Sep 6.
Sirtuin 1 (SIRT1) plays a critical role in the maintenance of metabolic homeostasis and promotes fat mobilization in white adipose tissue. However, regulation of SIRT1 during adipogenesis, particularly through microRNAs, remains unclear. We observed that miR-146b expression was markedly increased during adipogenesis in 3T3-L1 cells. Differentiation of 3T3-L1 was induced by overexpression of miR-146b. Conversely, inhibition of miR-146b decreased adipocyte differentiation. Bioinformatics-based studies suggested that SIRT1 is a target of miR-146b. Further analysis confirmed that SIRT1 was negatively regulated by miR-146b. We also observed that miR-146b bound directly to the 3'-untranslated region of SIRT1 and inhibited adipogenesis through SIRT1 downregulation. The miR-146b/SIRT1 axis mediates adipogenesis through increased acetylation of forkhead box O1 (FOXO1). Expression of miR-146b was increased and SIRT1 mRNA subsequently decreased in the adipose tissues of diet-induced and genetically obese mice. Furthermore, in vivo knockdown of miR-146b by a locked nucleic acid miR-146b antagomir significantly reduced body weight and fat volume in accordance with upregulation of SIRT1 and subsequent acetylation of FOXO1. Therefore, the miR-146b/SIRT1 pathway could be a potential target for obesity prevention and treatment.
Sirtuin 1 (SIRT1) 在维持代谢稳态和促进白色脂肪组织中脂肪动员方面发挥着关键作用。然而,SIRT1 在脂肪生成过程中的调控,特别是通过 microRNAs 的调控,仍然不清楚。我们观察到,miR-146b 在 3T3-L1 细胞的脂肪生成过程中表达明显增加。通过过表达 miR-146b 诱导 3T3-L1 的分化。相反,抑制 miR-146b 减少脂肪细胞分化。基于生物信息学的研究表明,SIRT1 是 miR-146b 的靶标。进一步的分析证实 SIRT1 受 miR-146b 的负调控。我们还观察到 miR-146b 直接与 SIRT1 的 3'-非翻译区结合,并通过 SIRT1 下调抑制脂肪生成。miR-146b/SIRT1 轴通过增加叉头框 O1 (FOXO1) 的乙酰化来介导脂肪生成。饮食诱导和遗传肥胖小鼠的脂肪组织中 miR-146b 的表达增加,随后 SIRT1 mRNA 减少。此外,体内通过锁定核酸 miR-146b 反义寡核苷酸抑制 miR-146b 的表达,可显著降低体重和脂肪体积,同时上调 SIRT1 和随后的 FOXO1 乙酰化。因此,miR-146b/SIRT1 通路可能是预防和治疗肥胖的潜在靶点。